About ETNHX
Eventide Healthcare & Life Sciences Fund Class N Shares is an open-end mutual fund focused on delivering long-term capital appreciation by investing primarily in the healthcare and life sciences sectors. The fund allocates at least 80% of its net assets to equity and equity-related securities of companies engaged in areas such as biotechnology, pharmaceuticals, diagnostics, life science tools, medical devices, healthcare information technology, and related services. It is not restricted by company market capitalization and can invest globally, including companies domiciled outside the United States directly or through American Depositary Receipts. The fund’s portfolio often includes both established firms and development-stage enterprises, reflecting its commitment to innovation and growth within the broader health industry.
Notably, the fund’s holdings span a range of healthcare subsectors, with significant concentrations in companies developing breakthrough therapeutics, medical technologies, and diagnostic solutions. With over $1 billion in assets under management and a diversified mix of holdings, the fund serves as a specialized vehicle for gaining exposure to the dynamic and evolving healthcare and life sciences landscape, a sector recognized for its critical role in global health and innovation.
Fund Family Eventide Funds
Category Health
Performance Rating Average
Risk Rating High
Stock Exchange Nasdaq
Ticker Symbol ETNHX
Share Class Class N Shares
Index S&P Biotechnology Select Industry TR
ETNHX had a total return of 19.02% in the past year, including dividends. Since the fund's
inception, the average annual return has been 14.17%.
